Gene Symbol | SPHK1 |
Entrez ID | 8877 |
Uniprot ID | Q9NYA1 |
Description | sphingosine kinase 1 |
Chromosomal Location | chr17: 76,376,584-76,387,860 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001568 |
blood vessel development |
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood. |
IEA |
BP |
GO:0003376 |
sphingosine-1-phosphate signaling pathway |
A series of molecular signals initiated by the sphingolipid sphingosine-1-phosphate (S1P) binding to a receptor on the surface of the cell, and which proceeds with the activated receptor transmitting the signal by promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
IEA |
BP |
GO:0006457 |
protein folding |
The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure. |
TAS |
BP |
GO:0006670 |
sphingosine metabolic process |
The chemical reactions and pathways involving sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues. |
IDA |
BP |
GO:0006954 |
inflammatory response |
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
IEA |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
BP |
GO:0007420 |
brain development |
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.). |
IEA |
BP |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation |
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. |
IMP |
BP |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway |
Any process that modulates the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor. |
IDA |
BP |
GO:0019722 |
calcium-mediated signaling |
Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions. |
IDA |
BP |
GO:0030148 |
sphingolipid biosynthetic process |
The chemical reactions and pathways resulting in the formation of sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid). |
TAS |
BP |
GO:0030307 |
positive regulation of cell growth |
Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
IDA |
BP |
GO:0030335 |
positive regulation of cell migration |
Any process that activates or increases the frequency, rate or extent of cell migration. |
IDA |
BP |
GO:0031398 |
positive regulation of protein ubiquitination |
Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
IDA |
BP |
GO:0032651 |
regulation of interleukin-1 beta production |
Any process that modulates the frequency, rate, or extent of interleukin-1 beta production. |
IEA |
BP |
GO:0035556 |
intracellular signal transduction |
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
TAS |
BP |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus |
Any process that activates or increases the frequency, rate or extent of transfer of NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters, from the cytoplasm into the nucleus, across the nuclear membrane. |
IMP |
BP |
GO:0043066 |
negative regulation of apoptotic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
IDA|TAS |
BP |
GO:0045766 |
positive regulation of angiogenesis |
Any process that activates or increases angiogenesis. |
IDA |
BP |
GO:0045931 |
positive regulation of mitotic cell cycle |
Any process that activates or increases the rate or extent of progression through the mitotic cell cycle. |
IDA |
BP |
GO:0045987 |
positive regulation of smooth muscle contraction |
Any process that activates or increases the frequency, rate or extent of smooth muscle contraction. |
IDA |
BP |
GO:0046512 |
sphingosine biosynthetic process |
The chemical reactions and pathways resulting in the formation of sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues. |
IGI|IMP |
BP |
GO:0046521 |
sphingoid catabolic process |
The chemical reactions and pathways resulting in the breakdown of sphingoids, any of a class of compounds comprising sphinganine and its homologues and stereoisomers, and derivatives of these compounds. |
NAS |
BP |
GO:0046834 |
lipid phosphorylation |
The process of introducing one or more phosphate groups into a lipid, any member of a group of substances soluble in lipid solvents but only sparingly soluble in aqueous solvents. |
IEA |
BP |
GO:0048146 |
positive regulation of fibroblast proliferation |
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
IDA |
BP |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity |
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
IMP |
CC |
GO:0005634 |
nucleus |
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
IEA |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
CC |
GO:0005829 |
cytosol |
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
TAS |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
IDA |
MF |
GO:0000287 |
magnesium ion binding |
Interacting selectively and non-covalently with magnesium (Mg) ions. |
IDA|ISS |
MF |
GO:0003677 |
DNA binding |
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
IDA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0005516 |
calmodulin binding |
Interacting selectively and non-covalently with calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states. |
IDA |
MF |
GO:0005524 |
ATP binding |
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
IDA |
MF |
GO:0008481 |
sphinganine kinase activity |
Catalysis of the reaction: ATP + sphinganine = ADP + sphinganine 1-phosphate. |
IDA|TAS |
MF |
GO:0017050 |
D-erythro-sphingosine kinase activity |
Catalysis of the reaction: sphingosine + ATP = sphingosine 1-phosphate + ADP. |
IDA|TAS |
MF |
GO:0038036 |
sphingosine-1-phosphate receptor activity |
Combining with the sphingolipid sphingosine-1-phosphate (S1P), and transmitting the signal across the membrane by activating an associated G-protein. |
IMP |
MF |
GO:0051721 |
protein phosphatase 2A binding |
Interacting selectively and non-covalently with the enzyme protein phosphatase 2A. |
IPI |
Domain ID | Description |
---|---|
IPR001206 |
Diacylglycerol kinase, catalytic domain |
IPR016064 |
NAD kinase/diacylglycerol kinase-like domain |
IPR017438 |
Inorganic polyphosphate/ATP-NAD kinase, domain 1 |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa00600 |
Sphingolipid metabolism |
KEGG |
hsa01100 |
Metabolic pathways |
KEGG |
hsa04020 |
Calcium signaling pathway |
KEGG |
hsa04071 |
Sphingolipid signaling pathway |
KEGG |
hsa04072 |
Phospholipase D signaling pathway |
KEGG |
hsa04370 |
VEGF signaling pathway |
KEGG |
hsa04371 |
Apelin signaling pathway |
KEGG |
hsa04666 |
Fc gamma R-mediated phagocytosis |
KEGG |
hsa05152 |
Tuberculosis |
KEGG |
WP26 |
Signal Transduction of S1P Receptor |
WikiPathways |
WP1422 |
Sphingolipid Metabolism |
WikiPathways |
h_edg1Pathway |
Phospholipids as signalling intermediaries |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0009324 |
Ulcerative Colitis |
C0016059 |
Fibrosis |
C0023418 |
Leukemia |
C3463824 |
Myelodysplastic Syndrome |
Pubmed ID | Author | Year | Title |
---|---|---|---|
15598877 |
Wood et al. |
2005 |
Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects |
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
LYN |
4067 |
P07948 |
0.52 |
MBTPS1 |
8720 |
Q14703 |
0.52 |
CYLD |
1540 |
Q9NQC7 |
0.63 |
DHPS |
1725 |
P49366 |
0.63 |
PPM1G |
5496 |
O15355 |
0.63 |
RARG |
5916 |
P13631 |
0.63 |
DCXR |
51181 |
Q7Z4W1 |
0.63 |
CTNND2 |
1501 |
Q9UQB3 |
0.65 |
FYN |
2534 |
P06241 |
0.65 |
BIRC3 |
330 |
Q13489 |
0.68 |
EEF1A1 |
1915 |
P68104 |
0.68 |
TRAF6 |
7189 |
Q9Y4K3 |
0.73 |
CTSB |
1508 |
P07858 |
0.80 |
TRAF2 |
7186 |
Q12933 |
0.90 |
KRAS |
3845 |
P01116 |
0.00 |
PLD1 |
5337 |
Q13393 |
0.00 |
PLD2 |
5338 |
O14939 |
0.00 |
EP300 |
2033 |
Q09472 |
0.52 |
FHL2 |
2274 |
Q14192 |
0.73 |
SPHKAP |
80309 |
Q2M3C7 |
0.76 |
RPS6KC1 |
26750 |
Q96S38 |
0.77 |